Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

Volume 16, no. 9, pages 1285-1292, 2009. Page 1287, Results, lines 1 and 2: “118 (93.7%) of the 126 subjects” should read “111 (91.7%) of the 121 subjects. . .”

Page 1291, Acknowledgments: Two V526-001 principal investigators were inadvertently omitted: M. Marmor, New York University, and K. Beutner, Dow Pharmaceutical Sciences.

Page 1291, Acknowledgments, line 9: “A. Myers, Body Positive” should read “R. Myers, Southwest Center for HIV/AIDS.”